A large British study published on Wednesday found Regeneron Pharmaceuticals Inc’s COVID-19 antibody cocktail reduces deaths in hospitalised patients who have not mounted their own antibody response.

Regeneron COVID-19 therapy cuts deaths among hospitalised patients who lack antibodies: Study

India has given emergency use authorization for a COVID-19 antibody-drug cocktail developed by Roche and Regeneron, expanding its arsenal of drugs to battle a massive second wave of infections.

India approves Roche/Regeneron antibody cocktail to treat COVID-19

Regeneron is pursuing US approval for its COVID-19 monoclonal antibody cocktail as a preventative treatment after it helped cut the risk of symptomatic infections in households where someone else is ill, the US drugmaker said on Monday.

Regeneron to seek US approval for COVID-19 cocktail to be used for prevention

When the former US President Donald Trump got infected by the deadly coronavirus, he claimed to have tried experimental Regeneron's synthetic antibody treatment, which reportedly worked as a magical cure against the virus.

Donald Trump's coronavirus 'cure' effective on UK, South African variants

When the former US President Donald Trump got infected by the deadly coronavirus, he claimed to have tried experimental antibodies, which reportedly worked as a magical cure against the virus.

Germany orders coronavirus drugs that cured Donald Trump

The United States has issued an emergency approval for a synthetic antibody therapy against Covid-19 that was notably used to treat President Donald Trump. The authorisation was given on Saturday to Regeneron Pharmaceuticals Inc's COVID-19 antibody therapy that Trump said helped cure him of the disease.

US grants emergency use authorisation to Regeneron Covid-19 antibodies

WASHINGTON — On Wednesday, President Donald Trump portrayed as a miracle “cure” the experimental antibody mixture he took for his case of COVID-19, which had landed him in Walter Reed National Medical Military Center just days before.

With ‘cure’ comment, Trump exaggerates known benefits of another COVID-19 therapy

After the US President Donald Trump claimed to have recovered from the novel coronavirus by a drug that can "cure" the virus, the popularity of this drug has increase manifolds.

More people willing to participate in Regeneron's trial after Trump calls it a 'cure'

President Donald Trump was treated on Friday for COVID-19 with a high-dose of the experimental antibody drug developed by the US biotech firm Regeneron. What is it, how far along are its clinical trials, and why do some experts disagree with using a medicine before it's been approved?

What you need to know about Regeneron's COVID-19 treatment

Regeneron Pharmaceuticals Inc on Thursday said it has begun human testing of its experimental antibody cocktail as a treatment for COVID-19, the disease caused by the novel coronavirus.

Regeneron begins human testing of COVID-19 antibody cocktail

regeneron

Regeneron, News on Regeneron, stories on Regeneron, articles on Regeneron, Regeneron stories at Wion, Regeneron news, Regeneron latest news